Laddar populära aktier...
Sales 5% vs. ABGSCe, adj. EBITA 7% vs. ABGSCe No material estimate changes Trading at 9-6x EV/EBITA on '24e-'26e (8-11% FCF yields) Adj.
- Q1e: -2% organic growth, adj. EBITA +12% y-o-y - We cut adj.
Adj. EBITA of SEK 63m, 0% vs. ABGSCe in Q4 FCF was softer because of negative working capital effect EBITA ests -4-5%; share is trading at 4...
Q4 due on 20 February; we forecast -2% org. growth EBITA cut 1% on '24e-'25e because of FX 4.
Revises MBXP financials, takes SEK 43m loss MBXP earnout reduced from SEK 125m to zero, lifts net cash Expect slight est cuts on lower long-...
Continued headwinds in Denmark and Germany in Q3 Underlying '24e-'25e EBITA cut 12-9%, but neutral incl.
Adj. EBITA SEK 12m, -50% vs. ABGSCe SEK 24m MBXP continued to hold back profitability, sales in line Consensus est's to come down 7-8% on '2...
Acquires IPO Prämien Services for EUR 7.8m Implied multiple of 16x-4x EBITDA on '22/23-'21/22 Could add 8% to 2042e adj.
• Reserves SEK 4.4m after Paygoo partner files for bankruptcy • Consensus 2023e EBITDA affected by ~4% • No further estimate revisions expec...
Margin pressure to persist but fade in coming quarters We cut EBITA by 16%, 8%, and 7% for '23e-'25e Share trading at 8x FCF and 6x EBITA on...
EBITA -50% vs. ABGSCe, in-line with PW Solid FCF driven by positive WC development Conference call at CET 10.
• Pre-announces Q2, EBITA SEK 14m vs. ABGSCe SEK 28m • Lower profitability in MBXP behind the miss • Cons.
• Q2 results due on 15 August • Expected to maintain stable organic growth of 5% • We also forecast slight pressure on profitability Expect ...
Solid org. growth of 12%, but a tad weaker profitability Adj.
Q1 adj. EBITA 11.5m vs. ABGSCe 13.5 Strong operational development and outlook No material changes to consensus estimates Organic growth st...
Q1e: 10% org. growth and margin expansion y-o-y Integration of Connex likely to hold back profitability 17% EBITA/sh CAGR in '22-'25e, tradi...
Q4'22 was strong across the board Expect strong organic growth and margin improvements 18% EBITA/sh CAGR ('21-'25e) trading at 11x EBITA '23...
Q4 EBITA SEK 58m (+9% vs. ABGSCe) Organic growth was 21% vs.
EBITA +77% vs. ABGSCe, 20% organic growth Positive wording around M&A Share trades at 9.
Reported EBITA of SEK 28m, +74% vs. ABGSCe Back to normal sooner than expected Share trading at 8x EV/EBITA on 2023e Q2 details Sales SEK 19...
Temporary issues isolated to H1, back to normal in H2 Organic development continues to be strong We are optimistic about the growth prospect...
Q1 EBITA hit by temporary problems in Germany Client activity in Germany to return to normal in H2’22e Share trades at 14x-9x EV/EBITA on 2...
Q1 sales -15% vs. ABG, EBITA margin 3% vs. ABG 12% Consensus estimates to come down Conference call at 10:00 CET Q1 details Sales of SEK 16...
Solutions that drive employee and customer retention Impressive combination of organic growth and M&A 32% EBITA CAGR ’21e-’23e; 16.